Home » Syntarga BV Closes Series A Financing
Syntarga BV Closes Series A Financing
April 15, 2005
Syntarga BV announced that it has realized a first round of financing. Allocation of funds will be towards the development of novel linker technologies for oncology products and the establishment of partnerships with biotechnology and pharmaceutical companies. The financing round was led by Aglaia Oncology Fund with BioPartner Start-up Ventures as co-investor.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19708420&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct